Measurement of the Glial Fibrillary Acidic Protein and Its Breakdown Products GFAP-BDP Biomarker for the Detection of Traumatic Brain Injury Compared to Computed Tomography and Magnetic Resonance Imaging

Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific proteins released into serum as part of the pathophysiological response after traumatic brain injury (TBI). We performed a multi-center trial to validate and characterize the use of GFAP-BDP levels in the diagno...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Neurotrauma
Autores principales: McMahon, Paul J., Panczykowski, David M., Yue, John K., Puccio, Ava M., Inoue, Tomoo, Sorani, Marco D., Lingsma, Hester F., Maas, Andrew I.R., Valadka, Alex B., Yuh, Esther L., Mukherjee, Pratik, Manley, Geoffrey T., Okonkwo, David O., Casey, Scott S., Cheong, Maxwell, Cooper, Shelly R., Dams-O'Connor, Kristen, Gordon, Wayne A., Hricik, Allison J., Lawless, Kerri, Menon, David, Schnyer, David M., Vassar, Mary J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394160/
https://ncbi.nlm.nih.gov/pubmed/25264814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/neu.2014.3635
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares